fenclonine has been researched along with Growth Disorders in 2 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benevenga, NJ | 1 |
| Steele, RD | 1 |
| Shah, SN | 1 |
| Johnson, RC | 1 |
1 review available for fenclonine and Growth Disorders
| Article | Year |
|---|---|
Adverse effects of excessive consumption of amino acids.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Animals; Brain; Cattle; Diet; Disease Models, Ani | 1984 |
1 other study available for fenclonine and Growth Disorders
| Article | Year |
|---|---|
Effect of postweaning hyperphenylalaninemia on brain development in rats: myelination, lipid, and fatty acid composition of myelin.
Topics: Animals; Animals, Suckling; Brain; Cerebrosides; Fatty Acids; Fenclonine; Growth Disorders; Myelin S | 1978 |